167 related articles for article (PubMed ID: 6741378)
1. [Immunologic sensitization to tumor-associated antigens during the growth of gliomas of the brain (experimental study)].
Novichenko NL; Romodanov AP; Zhmareva EN; Gorovoĭ AI
Zh Vopr Neirokhir Im N N Burdenko; 1984; (2):9-13. PubMed ID: 6741378
[TBL] [Abstract][Full Text] [Related]
2. Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.
Ciesielski MJ; Kazim AL; Barth RF; Fenstermaker RA
Cancer Immunol Immunother; 2005 Feb; 54(2):107-19. PubMed ID: 15340764
[TBL] [Abstract][Full Text] [Related]
3. Immunological reactions to gliomas.
Ridley A
Mod Trends Neurol; 1975; 6():249-66. PubMed ID: 1105142
[No Abstract] [Full Text] [Related]
4. Immunological aspects of experimental brain tumors (review).
Stavrou D; Bilzer T; Hultén M; Zänker KS; Anzil AP; Haglid KG; Dahme E
Anticancer Res; 1982; 2(3):151-5. PubMed ID: 6751209
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
6. Immunogenetic control of brain tumor growth in rats.
Albright AL; Gill TJ; Geyer SJ
Cancer Res; 1977 Aug; 37(8 Pt 1):2512-21. PubMed ID: 889589
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous regression of experimental gliomas--an immunohistochemical and MRI study of the C6 glioma spheroid implantation model.
Vince GH; Bendszus M; Schweitzer T; Goldbrunner RH; Hildebrandt S; Tilgner J; Klein R; Solymosi L; Christian Tonn J; Roosen K
Exp Neurol; 2004 Dec; 190(2):478-85. PubMed ID: 15530886
[TBL] [Abstract][Full Text] [Related]
8. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
[TBL] [Abstract][Full Text] [Related]
9. Modulation of tumor immunogenicity of rat glioma cells by s-Myc expression: eradication of rat gliomas in vivo.
Asai A; Miyagi Y; Hashimoto H; Lee SH; Mishima K; Sugiyama A; Tanaka H; Mochizuki T; Yasuda T; Kuchino Y
Cell Growth Differ; 1994 Nov; 5(11):1153-8. PubMed ID: 7848917
[TBL] [Abstract][Full Text] [Related]
10. Proceedings: Immunological investigations on human brain tumor patients.
Mahaley MS
Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
[No Abstract] [Full Text] [Related]
11. [Active immunotherapy of cerebral tumor. 20 cases].
Trouillas P; Lapras C
Neurochirurgie; 1970; 16(2):143-70. PubMed ID: 4317954
[No Abstract] [Full Text] [Related]
12. Gliomas: new ways of treatment?
van Acker RE
Clin Neurol Neurosurg; 1977; 80(2):112-5. PubMed ID: 209922
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of experimental active specific immunotherapy and immunoprevention of malignant gliomas of the brain].
Romodanov SA; Zatula DG; Lisianyĭ NI; Glavatskiĭ AIa; Prosvirneva GM
Zh Vopr Neirokhir Im N N Burdenko; 1986; (3):18-23. PubMed ID: 3739492
[TBL] [Abstract][Full Text] [Related]
14. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A
Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199
[TBL] [Abstract][Full Text] [Related]
15. Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination.
Graf MR; Prins RM; Hawkins WT; Merchant RE
Cancer Immunol Immunother; 2002 Jun; 51(4):179-89. PubMed ID: 12012105
[TBL] [Abstract][Full Text] [Related]
16. [The concept of the immunologic barrier of the brain].
Malashkhiia IuA; Geladze MG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(2):3-7. PubMed ID: 3376645
[TBL] [Abstract][Full Text] [Related]
17. Immunogenetic control of the immune response to gliosarcoma 9L growth in rats.
Geyer SJ; Landay A
Transplant Proc; 1981 Jun; 13(2):1407-9. PubMed ID: 7245333
[No Abstract] [Full Text] [Related]
18. lacZ-neoR transfected glioma cells in syngeneic rats: growth pattern and characterization of the host immune response against cells transplanted inside and outside the CNS.
Visted T; Thorsen J; Thorsen F; Read TA; Ulvestad E; Engebraaten O; Sorensen D; Ylä-Herttuala S; Tyynela K; Rucklidge G; Edvardsen K; Bjerkvig R; Lund-Johansen M
Int J Cancer; 2000 Jan; 85(2):228-35. PubMed ID: 10629082
[TBL] [Abstract][Full Text] [Related]
19. Models of monocytic invasion into glioma cell aggregates.
Strik HM; Hülper P; Erdlenbruch B; Meier J; Kowalewski A; Hemmerlein B; Gold R; Bähr M
Anticancer Res; 2006; 26(2A):865-71. PubMed ID: 16619481
[TBL] [Abstract][Full Text] [Related]
20. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]